Medial-frontal cortex hypometabolism in chronic phencyclidine exposed rats assessed by high resolution magic angle spin 11.7 T proton magnetic resonance spectroscopy

Neurochemistry International

Volumn 61, Issue 1, 2012, Pages 128-131

  Bustillo, Juan ^a,b   Galloway, Matthew P ^c   Ghoddoussi, Farhad ^c   Bolognani, Federico ^b,d   Perrone Bizzozero, Nora ^b  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NOVARTIS PHARMA AG   (Switzerland)

Author keywords

1H MRS; Glutamate; N acetyl aspartate; Phencyclidine; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID; ASPARTIC ACID; CHOLINE; CREATINE; GLUTAMIC ACID; GLUTAMINE; GLYCINE; LACTIC ACID; N ACETYLASPARTIC ACID; PHENCYCLIDINE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; BRAIN REGION; CINGULATE GYRUS; CONTROLLED STUDY; CORPUS STRIATUM; FRONTAL CORTEX; HIPPOCAMPUS; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; SCHIZOPHRENIA;

ANIMALS; FRONTAL LOBE; MAGNETIC RESONANCE SPECTROSCOPY; PHENCYCLIDINE; RATS;

RATTUS;

EID: 84862901198     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2012.04.003     Document Type: Article

References (15)

1. C. Abbott, and J. Bustillo What have we learned from proton magnetic resonance spectroscopy about schizophrenia? A critical update Curr. Opin. Psychiatry 19 2006 135 139
2. J. Bustillo, R. Barrow, R. Paz, J. Tang, N. Seraji-Bozorgzad, G. Moore, F. Bolognani, J. Lauriello, N. Perrone-Bizzozero, and M. Galloway Long term treatment of rats with haloperidol: lack of an effect on brain N-acetyl aspartate levels Neuropsychopharmacology 31 2006 751 756
3. S.M. Cochran, M. Kennedy, C.E. McKerchar, L.J. Steward, J.A. Pratt, and B.J. Morris Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs Neuropsychopharmacology 28 2003 265 275
4. F. Ghoddoussi, M.P. Galloway, A. Jambekar, M. Bame, R. Needleman, and W.S. Brusilow Methionine sulfoximine, an inhibitor of glutamine synthetase, lowers brain glutamine and glutamate in a mouse model of ALS J. Neurol. Sci. 290 2010 41 47
5. L.A. Glantz, and D.A. Lewis Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia Arch. Gen. Psychiatry 57 2000 65 73
6. T. Hajszan, C. Leranth, and R.H. Roth Subchronic phencyclidine treatment decreases the number of dendritic spine synapses in the rat prefrontal cortex Biol. Psychiatry 60 6 2006 639 644
7. P.J. Harrison, and D.R. Weinberger Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence Mol. Psychiatry 10 1 2005 40 68
8. B. Moghaddam, and D. Javitt From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment Neuropsychopharmacology 37 1 2012 4 15
9. B. Moghaddam, B. Adams, A. Verma, and D. Daly Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway for NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex J. Neuroscience 17 1992 2921 2927
10. J.A. Pratt, C. Winchester, A. Egerton, S.M. Cochran, and B.J. Morris Modeling prefrontal cortex deficits in schizophrenia: implications for treatment Br. J. Pharmacol 153 2008 S465 S470
11. L.M. Reynolds, S.M. Cochran, B.J. Morris, J.A. Pratt, and G.P. Reynolds Chronic phencyclidine administration induces schizophrenia-like changes in N-acetylaspartylglutamate in rat brain Schizophr. Res. 73 2005 147 152
12. L. Rowland, J. Bustillo, P. Mullins, R. Jung, R. Lenroot, E. Landgraf, R. Barrow, R. Yeo, J. Lauriello, and W. Brooks The effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4.0 T proton magnetic resonance spectroscopy study Am. J. Psychiatry 162 2005 394 396
13. L.D. Selemon, G. Rajkowska, and P.S. Goldman-Rakic Abnormally high neuronal density in the schizophrenic cortex Arch. Gen. Psychiatry 52 1995 805 819
14. R.G. Steen, R.M. Hamer, and J.A. Lieberman Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis Neuropsychopharmacology 30 11 2005 1949 1962
15. J. Yoon, R. Maddock, A. Rokem, M. Silver, M. Minzenberg, D. Ragland, and C. Carter GABA concentration is reduced in visual cortex in schizophrenia and correlates with orientation-specific surround uppression J. Neurosci. 30 10 2010 3777 3781